[
  {
    "title": "亚太药业(002370.SZ)：不向下修正“亚药转债”的转股价",
    "href": "http://stock.jrj.com.cn/2022/12/21185437229224.shtml",
    "datetime": "2022-12-21 18:54:27",
    "code": "002370"
  },
  {
    "title": "亚太药业：公司在国家组织的第七批药品集中带量采购中标的三个产品已按要求陆续开始供货",
    "href": "http://stock.jrj.com.cn/2022/12/20102237224767.shtml",
    "datetime": "2022-12-20 10:22:43",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：拟聘任中兴财光华会计师事务所为2022年度审计机构",
    "href": "http://stock.jrj.com.cn/2022/11/21182237155030.shtml",
    "datetime": "2022-11-21 18:22:27",
    "code": "002370"
  },
  {
    "title": "亚太药业：塞来昔布胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/14162437137107.shtml",
    "datetime": "2022-11-14 16:24:46",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：塞来昔布胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/11/14160137137060.shtml",
    "datetime": "2022-11-14 16:01:51",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)第三季度净亏损2945.43万元",
    "href": "http://stock.jrj.com.cn/2022/10/27215237091664.shtml",
    "datetime": "2022-10-27 21:52:13",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：“亚药转债”的转股价下修为8.5元/股",
    "href": "http://stock.jrj.com.cn/2022/09/08185436984072.shtml",
    "datetime": "2022-09-08 18:54:38",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)上半年净亏损5193.03万元，同比多亏18.26%",
    "href": "http://stock.jrj.com.cn/2022/08/26214636942915.shtml",
    "datetime": "2022-08-26 21:46:05",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：董事会提议向下修正可转债的转股价",
    "href": "http://stock.jrj.com.cn/2022/08/20172236918986.shtml",
    "datetime": "2022-08-20 17:22:29",
    "code": "002370"
  },
  {
    "title": "亚太药业：徐达因个人原因申请辞去公司监事职务",
    "href": "http://stock.jrj.com.cn/2022/08/04171036870828.shtml",
    "datetime": "2022-08-04 17:10:34",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业7月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/27180436847605.shtml",
    "datetime": "2022-07-27 18:04:40",
    "code": "002370"
  },
  {
    "title": "亚太药业2022年上半年预计亏损4500万-6000万同比亏损增加 销售费用减少",
    "href": "http://stock.jrj.com.cn/2022/07/14211036812967.shtml",
    "datetime": "2022-07-14 21:10:45",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：3项产品参与第七批国采拟中标",
    "href": "http://stock.jrj.com.cn/2022/07/13190736808388.shtml",
    "datetime": "2022-07-13 19:07:16",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：头孢克肟胶囊获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/07/11154936798908.shtml",
    "datetime": "2022-07-11 15:49:55",
    "code": "002370"
  },
  {
    "title": "亚太药业收2021年报问询函：要求年审会计师说明是否存在以保留意见代替无法表示意见",
    "href": "http://stock.jrj.com.cn/2022/05/18081036657294.shtml",
    "datetime": "2022-05-18 08:10:52",
    "code": "002370"
  },
  {
    "title": "A股异动 | 亚太药业(002370.SZ)涨停 富邦集团成公司控股股东",
    "href": "http://stock.jrj.com.cn/2022/04/20105636407991.shtml",
    "datetime": "2022-04-20 10:56:08",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：控股股东由无变更为富邦集团",
    "href": "http://stock.jrj.com.cn/2022/04/19214136402463.shtml",
    "datetime": "2022-04-19 21:41:45",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：注射用阿奇霉素通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/04/11161636303991.shtml",
    "datetime": "2022-04-11 16:16:37",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业3月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/28180535902859.shtml",
    "datetime": "2022-03-28 18:05:30",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业3月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/25180635125694.shtml",
    "datetime": "2022-03-25 18:06:32",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业3月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/24180434912566.shtml",
    "datetime": "2022-03-24 18:04:41",
    "code": "002370"
  },
  {
    "title": "亚太药业2021年预计亏损1.8亿-2.5亿同比由盈转亏 因集中采购政策推行等致使销售收入减少",
    "href": "http://stock.jrj.com.cn/2022/01/29203134257904.shtml",
    "datetime": "2022-01-29 20:31:54",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：通过高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2022/01/27170534230863.shtml",
    "datetime": "2022-01-27 17:05:11",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/25180534213117.shtml",
    "datetime": "2022-01-25 18:05:41",
    "code": "002370"
  },
  {
    "title": "安信证券涉亚太药业财务造假连收8张监管函",
    "href": "http://stock.jrj.com.cn/2022/01/25091934809381.shtml",
    "datetime": "2022-01-25 09:19:00",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/21180534183470.shtml",
    "datetime": "2022-01-21 18:05:11",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/18180534170490.shtml",
    "datetime": "2022-01-18 18:05:51",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/17180634165483.shtml",
    "datetime": "2022-01-17 18:06:14",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/14180534158493.shtml",
    "datetime": "2022-01-14 18:05:33",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/13180634154871.shtml",
    "datetime": "2022-01-13 18:06:41",
    "code": "002370"
  },
  {
    "title": "A股异动丨“幽门螺杆菌”龙头亚太药业(002370.SZ)收获五连板",
    "href": "http://stock.jrj.com.cn/2022/01/12133834149507.shtml",
    "datetime": "2022-01-12 13:38:39",
    "code": "002370"
  },
  {
    "title": "亚太药业：第一大股东拟受让7.27%公司股份",
    "href": "http://stock.jrj.com.cn/2022/01/11214734147787.shtml",
    "datetime": "2022-01-11 21:47:50",
    "code": "002370"
  },
  {
    "title": "亚太药业：第一大股东拟受让7.27%公司股份",
    "href": "http://stock.jrj.com.cn/2022/01/11202334147452.shtml",
    "datetime": "2022-01-11 20:23:26",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：宁波银行拟将所持7.27%股份协议转让予富邦集团",
    "href": "http://stock.jrj.com.cn/2022/01/11201234147421.shtml",
    "datetime": "2022-01-11 20:12:00",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/11180634146916.shtml",
    "datetime": "2022-01-11 18:06:31",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/07180634134305.shtml",
    "datetime": "2022-01-07 18:06:23",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：收到盐酸特拉唑嗪片一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2021/12/08171933985269.shtml",
    "datetime": "2021-12-08 17:19:28",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：亚太集团及钟婉珍被司法拍卖的3450万股已完成过户",
    "href": "http://stock.jrj.com.cn/2021/11/19162033880212.shtml",
    "datetime": "2021-11-19 16:20:30",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：公司变更为无控股股东、无实际控制人",
    "href": "http://stock.jrj.com.cn/2021/11/05222733818427.shtml",
    "datetime": "2021-11-05 22:27:29",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：枸橼酸莫沙必利颗粒获批上市",
    "href": "http://stock.jrj.com.cn/2021/11/04170533813159.shtml",
    "datetime": "2021-11-04 17:05:13",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)第三季度净亏损5119.72万元",
    "href": "http://stock.jrj.com.cn/2021/10/26190333756280.shtml",
    "datetime": "2021-10-26 19:03:02",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)第三季度预亏4500万–5500万元",
    "href": "http://stock.jrj.com.cn/2021/10/14164333691242.shtml",
    "datetime": "2021-10-14 16:43:01",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：注射用头孢美唑钠通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/22185933499875.shtml",
    "datetime": "2021-09-22 18:59:46",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：非布司他片上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2021/09/06170333392586.shtml",
    "datetime": "2021-09-06 17:03:13",
    "code": "002370"
  },
  {
    "title": "亚太药业2021年半年度亏损4391.18万元 同比亏损减少19.11%",
    "href": "http://stock.jrj.com.cn/2021/08/27222433336620.shtml",
    "datetime": "2021-08-27 22:24:15",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：实控人陈尧根及其配偶所持0.42%股份将被司法拍卖",
    "href": "http://stock.jrj.com.cn/2021/07/28185133165058.shtml",
    "datetime": "2021-07-28 18:51:51",
    "code": "002370"
  },
  {
    "title": "亚太药业2021年上半年预计亏损3500万-4500万 因集中采购政策推行等致使销售收入减少",
    "href": "http://stock.jrj.com.cn/2021/07/14231733097388.shtml",
    "datetime": "2021-07-14 23:17:57",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)上半年预亏3500万元-4500万元",
    "href": "http://stock.jrj.com.cn/2021/07/14192333096137.shtml",
    "datetime": "2021-07-14 19:23:03",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：两笔担保未履行相应审议程序、也未按规定进行信披 收到警示函",
    "href": "http://stock.jrj.com.cn/2021/07/07170433058845.shtml",
    "datetime": "2021-07-07 17:04:08",
    "code": "002370"
  },
  {
    "title": "亚太药业：公司目前暂无推出中药保健酒或者收购白酒厂家计划",
    "href": "http://stock.jrj.com.cn/2021/06/24154432989665.shtml",
    "datetime": "2021-06-24 15:44:09",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：抗乙肝药恩替卡韦片获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/18162432954921.shtml",
    "datetime": "2021-06-18 16:24:15",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：控股股东及其一致行动人被司法拍卖的2950万股完成过户",
    "href": "http://stock.jrj.com.cn/2021/06/16171732941196.shtml",
    "datetime": "2021-06-16 17:17:37",
    "code": "002370"
  },
  {
    "title": "亚太药业：公司滨海新城新厂区制剂生产线已通过GMP认证或现场检查",
    "href": "http://stock.jrj.com.cn/2021/05/26164832823720.shtml",
    "datetime": "2021-05-26 16:48:29",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)及子公司年初以来共获政府补助440.64万元",
    "href": "http://stock.jrj.com.cn/2021/05/12175932743028.shtml",
    "datetime": "2021-05-12 17:59:30",
    "code": "002370"
  },
  {
    "title": "亚太药业业绩爆雷后研发费用又“腰斩” 实控人卖股自救失败",
    "href": "http://stock.jrj.com.cn/2021/05/11081732734141.shtml",
    "datetime": "2021-05-11 08:17:00",
    "code": "002370"
  },
  {
    "title": "子公司财务造假致亚太药业遭行政处罚 民事索赔正式启动",
    "href": "http://stock.jrj.com.cn/2021/04/25072532436488.shtml",
    "datetime": "2021-04-25 07:25:49",
    "code": "002370"
  },
  {
    "title": "亚太药业违法实控人陈尧根遭禁入 安信证券项目杯具了",
    "href": "http://stock.jrj.com.cn/2021/04/22173432424116.shtml",
    "datetime": "2021-04-22 17:34:00",
    "code": "002370"
  },
  {
    "title": "亚太药业被罚被起诉后：靠 “意外之财”扭亏为盈 小微企业接盘或再生变数",
    "href": "http://stock.jrj.com.cn/2021/04/12070432355198.shtml",
    "datetime": "2021-04-12 07:04:22",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：亚太房地产持有的合计616.2万股已被百川瑞吉竞拍成功",
    "href": "http://stock.jrj.com.cn/2021/04/06164632319367.shtml",
    "datetime": "2021-04-06 16:46:15",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业3月31日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/31180632257240.shtml",
    "datetime": "2021-03-31 18:06:40",
    "code": "002370"
  },
  {
    "title": "亚太药业：公司利息费用主要为计提湖北省科技投资集团有限公司股权溢价收益、可转换公司债券应计利息",
    "href": "http://stock.jrj.com.cn/2021/03/29153432241221.shtml",
    "datetime": "2021-03-29 15:34:54",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年净利2727.5万：董事长陈尧根薪酬60.2万",
    "href": "http://stock.jrj.com.cn/2021/03/27090932226769.shtml",
    "datetime": "2021-03-27 09:09:09",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：“营销网络建设项目”延期",
    "href": "http://stock.jrj.com.cn/2021/03/26203332224382.shtml",
    "datetime": "2021-03-26 20:33:05",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：2020年度业绩扭亏为盈至2727.5万元",
    "href": "http://stock.jrj.com.cn/2021/03/26194632224144.shtml",
    "datetime": "2021-03-26 19:46:52",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：控股股东及其子公司所持2700万股将被司法拍卖",
    "href": "http://stock.jrj.com.cn/2021/03/22164332194731.shtml",
    "datetime": "2021-03-22 16:43:18",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：亚太集团及亚太房地产所持2700万股司法变卖已中止",
    "href": "http://stock.jrj.com.cn/2021/03/18192232158770.shtml",
    "datetime": "2021-03-18 19:22:05",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：控股股东所持公司股份将被司法拍卖1600万股",
    "href": "http://stock.jrj.com.cn/2021/03/12200032122322.shtml",
    "datetime": "2021-03-12 20:00:14",
    "code": "002370"
  },
  {
    "title": "A股异动 | 亚太药业(002370.SZ)涨逾4% 已累计收到拆迁补偿款1.863亿元",
    "href": "http://stock.jrj.com.cn/2021/03/11111932108263.shtml",
    "datetime": "2021-03-11 11:19:51",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)已累计收到拆迁补偿款1.863亿元",
    "href": "http://stock.jrj.com.cn/2021/03/10195732105239.shtml",
    "datetime": "2021-03-10 19:57:16",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：亚太房地产所持616.2万股司法拍卖股份2061.846万元成交",
    "href": "http://stock.jrj.com.cn/2021/03/09195432099383.shtml",
    "datetime": "2021-03-09 19:54:33",
    "code": "002370"
  },
  {
    "title": "实控人或遭5年证券市场禁入，部分持股将被变卖 亚太药业麻烦缠身",
    "href": "http://stock.jrj.com.cn/2021/03/02192232058894.shtml",
    "datetime": "2021-03-02 19:22:14",
    "code": "002370"
  },
  {
    "title": "亚太药业收购后标的财务造假3年 天健会计师所失职？",
    "href": "http://stock.jrj.com.cn/2021/03/02105732056062.shtml",
    "datetime": "2021-03-02 10:57:00",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：陈尧根夫妇所持3900万股将被司法变卖",
    "href": "http://stock.jrj.com.cn/2021/03/01170532050982.shtml",
    "datetime": "2021-03-01 17:05:57",
    "code": "002370"
  },
  {
    "title": "亚太药业子公司连续三年财务造假公布：虚增利润总额1.74亿 3月1日股价涨停",
    "href": "http://stock.jrj.com.cn/2021/03/01110132048834.shtml",
    "datetime": "2021-03-01 11:01:26",
    "code": "002370"
  },
  {
    "title": "亚太药业子公司上海新高峰连续三年虚增营收与利润，实控人及多位高管被罚",
    "href": "http://stock.jrj.com.cn/2021/03/01105632048773.shtml",
    "datetime": "2021-03-01 10:56:55",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：收到《行政处罚及市场禁入事先告知书》",
    "href": "http://stock.jrj.com.cn/2021/02/28164632040123.shtml",
    "datetime": "2021-02-28 16:46:27",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年度净利2727.5万同比扭亏为盈 收到柯桥厂区房屋拆迁补偿",
    "href": "http://stock.jrj.com.cn/2021/02/27112932037919.shtml",
    "datetime": "2021-02-27 11:29:24",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)业绩快报：2020年度业绩扭亏为盈至2727.5万元",
    "href": "http://stock.jrj.com.cn/2021/02/26204732035228.shtml",
    "datetime": "2021-02-26 20:47:53",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：实控人方面所持3900万股司法拍卖二次流拍",
    "href": "http://stock.jrj.com.cn/2021/02/22165032006455.shtml",
    "datetime": "2021-02-22 16:50:45",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：控股股东及其一致行动人所持2700万股将被司法变卖",
    "href": "http://stock.jrj.com.cn/2021/02/22164432006379.shtml",
    "datetime": "2021-02-22 16:44:02",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：实控人及其一致行动人所持3900万股将被第二次司法拍卖",
    "href": "http://stock.jrj.com.cn/2021/02/08173231870995.shtml",
    "datetime": "2021-02-08 17:32:52",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：亚太房地产持有的616.2万股将被司法拍卖",
    "href": "http://stock.jrj.com.cn/2021/02/05173831855343.shtml",
    "datetime": "2021-02-05 17:38:57",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：阿莫西林胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/02/05173631855338.shtml",
    "datetime": "2021-02-05 17:36:09",
    "code": "002370"
  },
  {
    "title": "亚太药业:控股股东亚太集团及其一致行动人收到执行裁定书",
    "href": "http://stock.jrj.com.cn/2021/02/04113031847817.shtml",
    "datetime": "2021-02-04 11:30:14",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/25180831767273.shtml",
    "datetime": "2021-01-25 18:08:41",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/22180631746284.shtml",
    "datetime": "2021-01-22 18:06:12",
    "code": "002370"
  },
  {
    "title": "躺赚？亚太药业在淘宝起拍价为3.85元 A股已6连板涨到5.45元",
    "href": "http://stock.jrj.com.cn/2021/01/21203331739595.shtml",
    "datetime": "2021-01-21 20:33:27",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：亚太房地产所持1600万股被司法变卖 成交价6462.5万元",
    "href": "http://stock.jrj.com.cn/2021/01/21185131738512.shtml",
    "datetime": "2021-01-21 18:51:53",
    "code": "002370"
  },
  {
    "title": "五连板的亚太药业(002370.SZ)：可能存在公司实际控制权发生变更的风险",
    "href": "http://stock.jrj.com.cn/2021/01/20224531731713.shtml",
    "datetime": "2021-01-20 22:45:09",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/20180731730315.shtml",
    "datetime": "2021-01-20 18:07:41",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/19180731722981.shtml",
    "datetime": "2021-01-19 18:07:02",
    "code": "002370"
  },
  {
    "title": "亚太药业靠拆迁补偿突击扭亏 11年累亏13亿陈尧根夫妇持股全部冻结",
    "href": "http://stock.jrj.com.cn/2021/01/19081531720146.shtml",
    "datetime": "2021-01-19 08:15:23",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：亚太集团及亚太房地产持有的共2700万股将被第二次司法拍卖",
    "href": "http://stock.jrj.com.cn/2021/01/17163731706435.shtml",
    "datetime": "2021-01-17 16:37:20",
    "code": "002370"
  },
  {
    "title": "两连板的亚太药业(002370.SZ)：不存在未披露的重大事项",
    "href": "http://stock.jrj.com.cn/2021/01/17163431706415.shtml",
    "datetime": "2021-01-17 16:34:59",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业1月15日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/15180631700302.shtml",
    "datetime": "2021-01-15 18:06:08",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年预计净利2000万-3000万 公司柯桥厂区房屋拆迁补偿",
    "href": "http://stock.jrj.com.cn/2021/01/13203331686151.shtml",
    "datetime": "2021-01-13 20:33:02",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：公司获塞来昔布胶囊药品注册受理通知书",
    "href": "http://stock.jrj.com.cn/2021/01/13173231685040.shtml",
    "datetime": "2021-01-13 17:32:04",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：2020年度扭亏为盈 预盈2000万元-3000万元",
    "href": "http://stock.jrj.com.cn/2021/01/13173031685021.shtml",
    "datetime": "2021-01-13 17:30:56",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：控股股东质押的2950万股展期",
    "href": "http://stock.jrj.com.cn/2021/01/08172631656186.shtml",
    "datetime": "2021-01-08 17:26:20",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)收到拆迁补偿款1.463亿元",
    "href": "http://stock.jrj.com.cn/2020/12/29191831596932.shtml",
    "datetime": "2020-12-29 19:18:47",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：签署拆迁补偿协议 拆迁补偿款总额约2.66亿元",
    "href": "http://stock.jrj.com.cn/2020/12/25215231572730.shtml",
    "datetime": "2020-12-25 21:52:03",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：收到注射用阿奇霉素及注射用奥美拉唑钠一致性评价的受理通知书",
    "href": "http://stock.jrj.com.cn/2020/12/07162831430898.shtml",
    "datetime": "2020-12-07 16:28:47",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：实控人及其一致行动人所持公司部分股份司法拍卖中止",
    "href": "http://stock.jrj.com.cn/2020/12/03181431401486.shtml",
    "datetime": "2020-12-03 18:14:27",
    "code": "002370"
  },
  {
    "title": "烫手！这家公司股份被拍卖后 买家宁可赔保证金也要反悔",
    "href": "http://stock.jrj.com.cn/2020/12/02075631389624.shtml",
    "datetime": "2020-12-02 07:56:05",
    "code": "002370"
  },
  {
    "title": "[亚太药业]强化理论武装,学习培训先行",
    "href": "http://stock.jrj.com.cn/2020/11/24000031339329.shtml",
    "datetime": "2020-11-24 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：实控人陈尧根及其配偶钟婉珍合计所持3900万股将被第二次司法拍卖",
    "href": "http://stock.jrj.com.cn/2020/11/20171531324526.shtml",
    "datetime": "2020-11-20 17:15:54",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：控股股东及其一致行动人所持3900万股司法拍卖股份流拍",
    "href": "http://stock.jrj.com.cn/2020/11/02171631201584.shtml",
    "datetime": "2020-11-02 17:16:36",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年前三季度亏损1.07亿由盈转亏 市场推广服务费增加",
    "href": "http://stock.jrj.com.cn/2020/10/27195031143924.shtml",
    "datetime": "2020-10-27 19:50:46",
    "code": "002370"
  },
  {
    "title": "亚太药业(002370.SZ)：前三季净亏损1.07亿元",
    "href": "http://stock.jrj.com.cn/2020/10/27171531142983.shtml",
    "datetime": "2020-10-27 17:15:05",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年前三季度亏损9500万-1.1亿 财务费用增加",
    "href": "http://stock.jrj.com.cn/2020/10/15113231058761.shtml",
    "datetime": "2020-10-15 11:32:45",
    "code": "002370"
  },
  {
    "title": "亚太药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15082031057334.shtml",
    "datetime": "2020-10-15 08:20:03",
    "code": "002370"
  },
  {
    "title": "大股东被迫卖股清偿债务 亚太药业造血能力堪忧",
    "href": "http://stock.jrj.com.cn/2020/09/22071430806974.shtml",
    "datetime": "2020-09-22 07:14:38",
    "code": "002370"
  },
  {
    "title": "亚太药业：子公司武汉光谷亚太医药研究院有限公司拟与黄石世星药业就原料药项目进行技术开发合作",
    "href": "http://stock.jrj.com.cn/2020/09/16122230761471.shtml",
    "datetime": "2020-09-16 12:22:21",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年上半年亏损5428.69万由盈转亏 终端市场销量下降",
    "href": "http://stock.jrj.com.cn/2020/08/27172530605201.shtml",
    "datetime": "2020-08-27 17:25:15",
    "code": "002370"
  },
  {
    "title": "【龙虎榜】亚太药业8月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/20180830550771.shtml",
    "datetime": "2020-08-20 18:08:22",
    "code": "002370"
  },
  {
    "title": "[互动]亚太药业：公司工业大麻项目未终止",
    "href": "http://stock.jrj.com.cn/2020/08/20142130548947.shtml",
    "datetime": "2020-08-20 14:21:50",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年上半年预计亏损5000万元至6000万元 销量有所下降",
    "href": "http://stock.jrj.com.cn/2020/07/15093830247040.shtml",
    "datetime": "2020-07-15 09:38:43",
    "code": "002370"
  },
  {
    "title": "亚太药业：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15084030245986.shtml",
    "datetime": "2020-07-15 08:40:32",
    "code": "002370"
  },
  {
    "title": "[亚太药业]七一建党节 ▏亚太药业开展“清洁家园,美化环境”主题党日活动",
    "href": "http://stock.jrj.com.cn/2020/07/03000030135152.shtml",
    "datetime": "2020-07-03 00:00:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]集团党委召开党员大会——选举新一届党委",
    "href": "http://stock.jrj.com.cn/2020/07/02000030123696.shtml",
    "datetime": "2020-07-02 00:00:00",
    "code": "002370"
  },
  {
    "title": "曾辉煌3年 现命悬并购 深陷巨亏旋涡的亚太药业将何去何从？",
    "href": "http://stock.jrj.com.cn/2020/05/26080329765125.shtml",
    "datetime": "2020-05-26 08:03:10",
    "code": "002370"
  },
  {
    "title": "亚太药业收深交所问询函 偿债能力、内控制度成问询重点",
    "href": "http://stock.jrj.com.cn/2020/05/15215529684390.shtml",
    "datetime": "2020-05-15 21:55:24",
    "code": "002370"
  },
  {
    "title": "亚太药业多重困局缠身 2019年亏损超上市以来利润总和",
    "href": "http://stock.jrj.com.cn/2020/05/08084529615853.shtml",
    "datetime": "2020-05-08 08:45:40",
    "code": "002370"
  },
  {
    "title": "亚太药业2020年第一季度亏损2480.74万元 销售收入减少",
    "href": "http://stock.jrj.com.cn/2020/05/01184129440814.shtml",
    "datetime": "2020-05-01 18:41:40",
    "code": "002370"
  },
  {
    "title": "亚太药业：收到注射用头孢美唑钠一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2020/04/17211029315747.shtml",
    "datetime": "2020-04-17 21:10:00",
    "code": "002370"
  },
  {
    "title": "亚太药业股东钟建富减持664万股 套现约4250万元",
    "href": "http://stock.jrj.com.cn/2020/03/27223429130634.shtml",
    "datetime": "2020-03-27 22:34:12",
    "code": "002370"
  },
  {
    "title": "56股预晒一季报 亚太药业成唯一亏损",
    "href": "http://stock.jrj.com.cn/2020/03/17005529036032.shtml",
    "datetime": "2020-03-17 00:55:59",
    "code": "002370"
  },
  {
    "title": "亚太药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/03/13212029022836.shtml",
    "datetime": "2020-03-13 21:20:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：2019年度亏损20.69亿元",
    "href": "http://stock.jrj.com.cn/2020/03/13205529022711.shtml",
    "datetime": "2020-03-13 20:55:14",
    "code": "002370"
  },
  {
    "title": "亚太药业：2019年亏损20.69亿元",
    "href": "http://stock.jrj.com.cn/2020/03/13202429022599.shtml",
    "datetime": "2020-03-13 20:24:00",
    "code": "002370"
  },
  {
    "title": "制药板块业绩前瞻：誉衡药业、亚太药业亏损超20亿 行业利润增速放缓",
    "href": "http://stock.jrj.com.cn/2020/03/06073328964833.shtml",
    "datetime": "2020-03-06 07:33:30",
    "code": "002370"
  },
  {
    "title": "业绩崩塌 信披违规被调查 五年前的那次收购让亚太药业跌入万丈深渊",
    "href": "http://stock.jrj.com.cn/2020/03/04080928949511.shtml",
    "datetime": "2020-03-04 08:09:00",
    "code": "002370"
  },
  {
    "title": "亚太药业2019年亏损20.69亿 水电气及人工工资费用增加",
    "href": "http://stock.jrj.com.cn/2020/02/29135628919557.shtml",
    "datetime": "2020-02-29 13:56:00",
    "code": "002370"
  },
  {
    "title": "子公司失控亚太药业确认投资损失12.4亿 CRO业务停顿",
    "href": "http://stock.jrj.com.cn/2020/02/26175428898272.shtml",
    "datetime": "2020-02-26 17:54:52",
    "code": "002370"
  },
  {
    "title": "亚太药业拟计提减值投资损失18亿 超上市以来净利总和两倍",
    "href": "http://stock.jrj.com.cn/2020/02/26103728895446.shtml",
    "datetime": "2020-02-26 10:37:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：拟计提减值准备、确认投资损失合计18.38亿元",
    "href": "http://stock.jrj.com.cn/2020/02/25210228892394.shtml",
    "datetime": "2020-02-25 21:02:32",
    "code": "002370"
  },
  {
    "title": "亚太药业：本次计提减值准备、确认投资损失合计18.38亿元",
    "href": "http://stock.jrj.com.cn/2020/02/25210128892389.shtml",
    "datetime": "2020-02-25 21:01:07",
    "code": "002370"
  },
  {
    "title": "亚太药业：拟计提减值准备、确认投资损失18.38亿元",
    "href": "http://stock.jrj.com.cn/2020/02/25201128892172.shtml",
    "datetime": "2020-02-25 20:11:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：计提减值准备、确认投资损失合计18.38亿元",
    "href": "http://stock.jrj.com.cn/2020/02/25195128892096.shtml",
    "datetime": "2020-02-25 19:51:13",
    "code": "002370"
  },
  {
    "title": "[亚太药业]柯桥区人大领导走访我公司",
    "href": "http://stock.jrj.com.cn/2020/02/24000029950282.shtml",
    "datetime": "2020-02-24 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业披露实控人等股份遭冻结 1月初已发生为何信披滞缓？",
    "href": "http://stock.jrj.com.cn/2020/02/21234628874016.shtml",
    "datetime": "2020-02-21 23:46:15",
    "code": "002370"
  },
  {
    "title": "[亚太药业]市经信局领导来我司开展“送防疫物资、强复产指导” 专题活动",
    "href": "http://stock.jrj.com.cn/2020/02/18000029950280.shtml",
    "datetime": "2020-02-18 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：公司抗病毒类药品注射用利巴韦林适用于病毒性呼吸道感染及其他病毒引起的感染",
    "href": "http://stock.jrj.com.cn/2020/02/06095828782207.shtml",
    "datetime": "2020-02-06 09:58:59",
    "code": "002370"
  },
  {
    "title": "部分医药股高开后大幅跳水 亚太药业跌8%",
    "href": "http://stock.jrj.com.cn/2020/02/03093928751332.shtml",
    "datetime": "2020-02-03 09:39:00",
    "code": "002370"
  },
  {
    "title": "亚太药业2019年度预计净利亏损15亿元–21亿元",
    "href": "http://stock.jrj.com.cn/2020/01/23170528728171.shtml",
    "datetime": "2020-01-23 17:05:07",
    "code": "002370"
  },
  {
    "title": "亚太药业：2019年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2020/01/23075028725613.shtml",
    "datetime": "2020-01-23 07:50:06",
    "code": "002370"
  },
  {
    "title": "[亚太药业]亚太药业与BBT、RI公司 ——加拿大工业大麻项目正式签约",
    "href": "http://stock.jrj.com.cn/2020/01/20000029950278.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业被冻结1个亿 深交所发函询问是否对公司经营产生影响",
    "href": "http://stock.jrj.com.cn/2020/01/14165728675758.shtml",
    "datetime": "2020-01-14 16:57:57",
    "code": "002370"
  },
  {
    "title": "亚太药业支柱子公司离奇失控 营收、采购数据勾稽均有异常",
    "href": "http://stock.jrj.com.cn/2020/01/12093628663095.shtml",
    "datetime": "2020-01-12 09:36:48",
    "code": "002370"
  },
  {
    "title": "亚太药业：三个银行账户被冻结 未对经营管理造成实质性影响",
    "href": "http://stock.jrj.com.cn/2020/01/10202928659928.shtml",
    "datetime": "2020-01-10 20:29:00",
    "code": "002370"
  },
  {
    "title": "“内讧”持续：亚太药业欲免去子公司董事长在上市公司职务",
    "href": "http://stock.jrj.com.cn/2020/01/07201328638831.shtml",
    "datetime": "2020-01-07 20:13:08",
    "code": "002370"
  },
  {
    "title": "亚太药业收关注函：不合并全资子公司报表被董事投诉",
    "href": "http://stock.jrj.com.cn/2020/01/03182928625510.shtml",
    "datetime": "2020-01-03 18:29:51",
    "code": "002370"
  },
  {
    "title": "亚太药业收关注函：要求详细说明不再将上海新高峰纳入公司合并报表范围的判断依据",
    "href": "http://stock.jrj.com.cn/2020/01/03170828625088.shtml",
    "datetime": "2020-01-03 17:08:32",
    "code": "002370"
  },
  {
    "title": "亚太药业涉信披违规遭立案调查 子公司失控商誉减值或达6.7亿",
    "href": "http://stock.jrj.com.cn/2020/01/03095228622903.shtml",
    "datetime": "2020-01-03 09:52:22",
    "code": "002370"
  },
  {
    "title": "亚太药业：公司董事任军遭证监会立案调查",
    "href": "http://stock.jrj.com.cn/2020/01/02165728618002.shtml",
    "datetime": "2020-01-02 16:57:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：公司董事收到证监会立案调查通知书",
    "href": "http://stock.jrj.com.cn/2020/01/02165128617972.shtml",
    "datetime": "2020-01-02 16:51:32",
    "code": "002370"
  },
  {
    "title": "亚太药业被证监会立案调查 今日股价涨0.78%",
    "href": "http://stock.jrj.com.cn/2020/01/02111228616634.shtml",
    "datetime": "2020-01-02 11:12:48",
    "code": "002370"
  },
  {
    "title": "亚太药业：涉嫌信披违法违规 遭证监会立案调查",
    "href": "http://stock.jrj.com.cn/2020/01/02073928615266.shtml",
    "datetime": "2020-01-02 07:39:53",
    "code": "002370"
  },
  {
    "title": "公告精选：*ST凯瑞子公司无偿受赠近2亿元股权资产；亚太药业涉嫌信披违规遭立案调",
    "href": "http://stock.jrj.com.cn/2020/01/01201728614125.shtml",
    "datetime": "2020-01-01 20:17:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：因公司涉嫌信息披露违法违规 证监会决定对公司进行立案调查",
    "href": "http://stock.jrj.com.cn/2020/01/01162628613708.shtml",
    "datetime": "2020-01-01 16:26:52",
    "code": "002370"
  },
  {
    "title": "亚太药业：涉嫌信披违法违规 遭证监会立案调查",
    "href": "http://stock.jrj.com.cn/2020/01/01162628613707.shtml",
    "datetime": "2020-01-01 16:26:00",
    "code": "002370"
  },
  {
    "title": "亚太药业4年前斥资9亿收购资产却带来6.7亿“坏账” 如今又失控了",
    "href": "http://stock.jrj.com.cn/2019/12/26063928587717.shtml",
    "datetime": "2019-12-26 06:39:15",
    "code": "002370"
  },
  {
    "title": "功臣变累赘 亚太药业子公司失控",
    "href": "http://stock.jrj.com.cn/2019/12/26000528587291.shtml",
    "datetime": "2019-12-26 00:05:36",
    "code": "002370"
  },
  {
    "title": "并购爆雷！9亿买来的子公司失控 亚太药业股民哭了",
    "href": "http://stock.jrj.com.cn/2019/12/25131728584571.shtml",
    "datetime": "2019-12-25 13:17:35",
    "code": "002370"
  },
  {
    "title": "子公司上海新高峰失去控制 亚太药业股价低开逾8%",
    "href": "http://stock.jrj.com.cn/2019/12/25093528583466.shtml",
    "datetime": "2019-12-25 09:35:03",
    "code": "002370"
  },
  {
    "title": "25日公司新闻聚焦：圣农发展拟10派15元 亚太药业子公司失去控制",
    "href": "http://stock.jrj.com.cn/2019/12/25092928583659.shtml",
    "datetime": "2019-12-25 09:29:00",
    "code": "002370"
  },
  {
    "title": "子公司失控业绩陡降 实控人质押85%股权 亚太药业摊上事儿了",
    "href": "http://stock.jrj.com.cn/2019/12/25081828583270.shtml",
    "datetime": "2019-12-25 08:18:00",
    "code": "002370"
  },
  {
    "title": "重要子公司失控 这家公司炸雷！股东难眠：平安夜不平安",
    "href": "http://stock.jrj.com.cn/2019/12/25073928583126.shtml",
    "datetime": "2019-12-25 07:39:35",
    "code": "002370"
  },
  {
    "title": "亚太药业称对上海新高峰失去控制",
    "href": "http://stock.jrj.com.cn/2019/12/25042328581562.shtml",
    "datetime": "2019-12-25 04:23:26",
    "code": "002370"
  },
  {
    "title": "A股又一则并购爆雷 亚太药业称子公司上海新高峰失控",
    "href": "http://stock.jrj.com.cn/2019/12/24235628581448.shtml",
    "datetime": "2019-12-24 23:56:19",
    "code": "002370"
  },
  {
    "title": "亚太药业子公司上海新高峰失去控制",
    "href": "http://stock.jrj.com.cn/2019/12/24223828581155.shtml",
    "datetime": "2019-12-24 22:38:50",
    "code": "002370"
  },
  {
    "title": "亚太药业：子公司上海新高峰失去控制",
    "href": "http://stock.jrj.com.cn/2019/12/24203028580895.shtml",
    "datetime": "2019-12-24 20:30:57",
    "code": "002370"
  },
  {
    "title": "亚太药业：子公司失去控制",
    "href": "http://stock.jrj.com.cn/2019/12/24201528580874.shtml",
    "datetime": "2019-12-24 20:15:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]公司组织开展职工急救知识培训",
    "href": "http://stock.jrj.com.cn/2019/11/14000029950281.shtml",
    "datetime": "2019-11-14 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业2名股东合计质押600万股 2019年上半年净利同比下滑69%",
    "href": "http://stock.jrj.com.cn/2019/11/10131628375928.shtml",
    "datetime": "2019-11-10 13:16:27",
    "code": "002370"
  },
  {
    "title": "亚太药业前三季度盈利691万 同比减少96%",
    "href": "http://stock.jrj.com.cn/2019/11/01115528338020.shtml",
    "datetime": "2019-11-01 11:55:38",
    "code": "002370"
  },
  {
    "title": "亚太药业业绩“爆雷” 重要子公司董事长称工作受严重阻碍",
    "href": "http://stock.jrj.com.cn/2019/10/29225228320743.shtml",
    "datetime": "2019-10-29 22:52:48",
    "code": "002370"
  },
  {
    "title": "亚太药业：料将计提商誉减值 全年预计亏损6.5亿至7.5亿元",
    "href": "http://stock.jrj.com.cn/2019/10/29195228319992.shtml",
    "datetime": "2019-10-29 19:52:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：自查发现子公司存在违规担保事项",
    "href": "http://stock.jrj.com.cn/2019/10/27194628305581.shtml",
    "datetime": "2019-10-27 19:46:18",
    "code": "002370"
  },
  {
    "title": "亚太药业：自查发现子公司存在违规担保事项",
    "href": "http://stock.jrj.com.cn/2019/10/27174828305340.shtml",
    "datetime": "2019-10-27 17:48:00",
    "code": "002370"
  },
  {
    "title": "亚太药业及子公司获得政府补助1656万元",
    "href": "http://stock.jrj.com.cn/2019/10/25222228302677.shtml",
    "datetime": "2019-10-25 22:22:41",
    "code": "002370"
  },
  {
    "title": "亚太药业：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/15085028247657.shtml",
    "datetime": "2019-10-15 08:50:00",
    "code": "002370"
  },
  {
    "title": "亚太药业两股东拟合计减持不超2.98%股份",
    "href": "http://stock.jrj.com.cn/2019/09/20212128161828.shtml",
    "datetime": "2019-09-20 21:21:48",
    "code": "002370"
  },
  {
    "title": "亚太药业股东拟减持不超2.98%股份",
    "href": "http://stock.jrj.com.cn/2019/09/20210528161359.shtml",
    "datetime": "2019-09-20 21:05:33",
    "code": "002370"
  },
  {
    "title": "亚太药业：股东拟减持不超2.98%股份",
    "href": "http://stock.jrj.com.cn/2019/09/20205328161249.shtml",
    "datetime": "2019-09-20 20:53:34",
    "code": "002370"
  },
  {
    "title": "亚太药业：关于非公开发行限售股份上市流通提示性公告",
    "href": "http://stock.jrj.com.cn/2019/09/16212028137012.shtml",
    "datetime": "2019-09-16 21:20:00",
    "code": "002370"
  },
  {
    "title": "多家子公司亏损 亚太药业经营利润下降2/3",
    "href": "http://stock.jrj.com.cn/2019/09/10181028117246.shtml",
    "datetime": "2019-09-10 18:10:24",
    "code": "002370"
  },
  {
    "title": "亚太药业：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/30215028070089.shtml",
    "datetime": "2019-08-30 21:50:00",
    "code": "002370"
  },
  {
    "title": "亚太药业2019年上半年净利4024万 子公司项目运营未达预期",
    "href": "http://stock.jrj.com.cn/2019/08/30195228068598.shtml",
    "datetime": "2019-08-30 19:52:31",
    "code": "002370"
  },
  {
    "title": "亚太药业股东钟婉珍质押400万股 公司去年净利同比增长3%",
    "href": "http://stock.jrj.com.cn/2019/08/25162328028469.shtml",
    "datetime": "2019-08-25 16:23:42",
    "code": "002370"
  },
  {
    "title": "亚太药业2名股东合计解除质押1600万股",
    "href": "http://stock.jrj.com.cn/2019/08/13171927970364.shtml",
    "datetime": "2019-08-13 17:19:56",
    "code": "002370"
  },
  {
    "title": "亚太药业2019年上半年盈利3284万元–7224万元 同比下降45%-75%",
    "href": "http://stock.jrj.com.cn/2019/07/15120327841207.shtml",
    "datetime": "2019-07-15 12:03:59",
    "code": "002370"
  },
  {
    "title": "亚太药业：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/14222027838625.shtml",
    "datetime": "2019-07-14 22:20:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：在加拿大合资建设工业大麻生产项目获商务等部门备案",
    "href": "http://stock.jrj.com.cn/2019/07/14164027837994.shtml",
    "datetime": "2019-07-14 16:40:33",
    "code": "002370"
  },
  {
    "title": "亚太药业拟出资3584万元设立合资公司 着力开拓欧美工业大麻CBD市场",
    "href": "http://stock.jrj.com.cn/2019/05/27184027627663.shtml",
    "datetime": "2019-05-27 18:40:49",
    "code": "002370"
  },
  {
    "title": "亚太药业：拟设立合资公司 在大麻产业领域开展合作",
    "href": "http://stock.jrj.com.cn/2019/05/27171327627244.shtml",
    "datetime": "2019-05-27 17:13:29",
    "code": "002370"
  },
  {
    "title": "亚太药业宣布进军大麻产业 深交所火速发关注函",
    "href": "http://stock.jrj.com.cn/2019/05/08195227543936.shtml",
    "datetime": "2019-05-08 19:52:32",
    "code": "002370"
  },
  {
    "title": "深交所对亚太药业下发关注函 要求说明开展工业大麻领域合作的可行性",
    "href": "http://stock.jrj.com.cn/2019/05/08120627542106.shtml",
    "datetime": "2019-05-08 12:06:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：与加拿大公司签订战略协议 布局工业大麻领域",
    "href": "http://stock.jrj.com.cn/2019/05/07175927538262.shtml",
    "datetime": "2019-05-07 17:59:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：有意在工业大麻领域开展药物研发及多领域商业化布局",
    "href": "http://stock.jrj.com.cn/2019/05/07175727538193.shtml",
    "datetime": "2019-05-07 17:57:34",
    "code": "002370"
  },
  {
    "title": "亚太药业：有意在工业大麻领域开展药物研发",
    "href": "http://stock.jrj.com.cn/2019/05/07175627538191.shtml",
    "datetime": "2019-05-07 17:56:36",
    "code": "002370"
  },
  {
    "title": "亚太药业一季度净利5679万元同比减少13% 现金流量净额为379万元",
    "href": "http://stock.jrj.com.cn/2019/05/05103427523601.shtml",
    "datetime": "2019-05-05 10:34:18",
    "code": "002370"
  },
  {
    "title": "亚太药业去年净利2.08亿同比增长3% 董事长陈尧根薪酬为50万元",
    "href": "http://stock.jrj.com.cn/2019/04/29232027509733.shtml",
    "datetime": "2019-04-29 23:20:05",
    "code": "002370"
  },
  {
    "title": "亚太药业：粉针剂（头孢菌素类）获药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/02/28161927102278.shtml",
    "datetime": "2019-02-28 16:19:12",
    "code": "002370"
  },
  {
    "title": "亚太药业：国研医药减持17.5万股 持股比例低于5%",
    "href": "http://stock.jrj.com.cn/2019/02/26185927093130.shtml",
    "datetime": "2019-02-26 18:59:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：获得头孢氨苄胶囊一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2019/02/25163527084783.shtml",
    "datetime": "2019-02-25 16:35:00",
    "code": "002370"
  },
  {
    "title": "亚太药业股东何珍增持35万股 耗资331万元",
    "href": "http://stock.jrj.com.cn/2019/02/17101527050953.shtml",
    "datetime": "2019-02-17 10:15:18",
    "code": "002370"
  },
  {
    "title": "午间公告：兴齐眼药新药获临床试验通知书；亚太药业董事拟增持30万股至60万股",
    "href": "http://stock.jrj.com.cn/2019/01/29120626996409.shtml",
    "datetime": "2019-01-29 12:06:00",
    "code": "002370"
  },
  {
    "title": "亚太药业遭遇闪崩 连续三日跌停",
    "href": "http://stock.jrj.com.cn/2019/01/22100426939937.shtml",
    "datetime": "2019-01-22 10:04:46",
    "code": "002370"
  },
  {
    "title": "亚太药业闪崩跌停",
    "href": "http://stock.jrj.com.cn/2019/01/18131026924133.shtml",
    "datetime": "2019-01-18 13:10:23",
    "code": "002370"
  },
  {
    "title": "亚太药业：全资子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/08075926870967.shtml",
    "datetime": "2019-01-08 07:59:59",
    "code": "002370"
  },
  {
    "title": "亚太药业股东亚太房地产质押1600万股 占其所持股份的39.35%",
    "href": "http://stock.jrj.com.cn/2018/11/13132925339116.shtml",
    "datetime": "2018-11-13 13:29:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/28221025269318.shtml",
    "datetime": "2018-10-28 22:10:00",
    "code": "002370"
  },
  {
    "title": "亚太药业获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2018/10/08165225170297.shtml",
    "datetime": "2018-10-08 16:52:40",
    "code": "002370"
  },
  {
    "title": "亚太药业：取得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2018/10/08163025170198.shtml",
    "datetime": "2018-10-08 16:30:00",
    "code": "002370"
  },
  {
    "title": "亚太药业2名股东合计减持1073万股 权益变动后各持股比例为2.73%",
    "href": "http://stock.jrj.com.cn/2018/09/28171325150175.shtml",
    "datetime": "2018-09-28 17:13:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：现折价大宗交易 机构买入1.3亿元",
    "href": "http://stock.jrj.com.cn/2018/09/25170025135661.shtml",
    "datetime": "2018-09-25 17:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：两股东拟合计减持不超5.96%股份",
    "href": "http://stock.jrj.com.cn/2018/08/29210025021484.shtml",
    "datetime": "2018-08-29 21:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业两股东拟合计减持不超5.96%股份",
    "href": "http://stock.jrj.com.cn/2018/08/29190325021130.shtml",
    "datetime": "2018-08-29 19:03:56",
    "code": "002370"
  },
  {
    "title": "亚太药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/28213025015778.shtml",
    "datetime": "2018-08-28 21:30:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：拟公开发行不超9.65亿元可转债",
    "href": "http://stock.jrj.com.cn/2018/07/23212524852279.shtml",
    "datetime": "2018-07-23 21:25:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：珠海节信、国研医药分别受让公司5.03%股权",
    "href": "http://stock.jrj.com.cn/2018/07/09193524788937.shtml",
    "datetime": "2018-07-09 19:35:00",
    "code": "002370"
  },
  {
    "title": "亚太药业2017年净利润2.02亿元 同比增长61.35%",
    "href": "http://stock.jrj.com.cn/2018/04/21094424426351.shtml",
    "datetime": "2018-04-21 09:44:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/20224024425306.shtml",
    "datetime": "2018-04-20 22:40:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]中共浙江亚太集团药业支部委员会主题党日活动",
    "href": "http://stock.jrj.com.cn/2018/04/18000024409673.shtml",
    "datetime": "2018-04-18 00:00:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]我公司工会被授予“2017年度绍兴市先进职工之家”荣誉称号",
    "href": "http://stock.jrj.com.cn/2018/04/03000024401929.shtml",
    "datetime": "2018-04-03 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：拟联合东方泓泰收购资产",
    "href": "http://stock.jrj.com.cn/hotstock/2018/02/22075924133950.shtml",
    "datetime": "2018-02-22 07:59:56",
    "code": "002370"
  },
  {
    "title": "[亚太药业]我公司荣获“柯桥区重才爱才先进单位”荣誉称号",
    "href": "http://stock.jrj.com.cn/2018/01/02000023882256.shtml",
    "datetime": "2018-01-02 00:00:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]我司员工参加“华东杯”职工书画比赛",
    "href": "http://stock.jrj.com.cn/2017/12/01000023883894.shtml",
    "datetime": "2017-12-01 00:00:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]热烈庆祝亚太药业2017年“庆国庆 迎中秋”文艺晚会圆满结束",
    "href": "http://stock.jrj.com.cn/2017/09/30000023883893.shtml",
    "datetime": "2017-09-30 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业：拟对全资子公司兴亚药业增资5800万元",
    "href": "http://stock.jrj.com.cn/hotstock/2017/09/15075923118256.shtml",
    "datetime": "2017-09-15 07:59:55",
    "code": "002370"
  },
  {
    "title": "亚太药业：使用部分募集资金设立武汉光谷全资子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2017/08/23075922984442.shtml",
    "datetime": "2017-08-23 07:59:52",
    "code": "002370"
  },
  {
    "title": "亚太药业：2017年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/08/22180022981860.shtml",
    "datetime": "2017-08-22 18:00:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]公司组织朱家尖、桃花岛两日游",
    "href": "http://stock.jrj.com.cn/2017/08/21000023883895.shtml",
    "datetime": "2017-08-21 00:00:00",
    "code": "002370"
  },
  {
    "title": "亚太药业拟推中期高送转",
    "href": "http://stock.jrj.com.cn/2017/08/13205222889042.shtml",
    "datetime": "2017-08-13 20:52:58",
    "code": "002370"
  },
  {
    "title": "[亚太药业]姚国海副书记慰问我公司一线科技工作者",
    "href": "http://stock.jrj.com.cn/2017/05/26000023882257.shtml",
    "datetime": "2017-05-26 00:00:00",
    "code": "002370"
  },
  {
    "title": "[亚太药业]公司开展“五四”青年节主题活动",
    "href": "http://stock.jrj.com.cn/2017/05/05000023882258.shtml",
    "datetime": "2017-05-05 00:00:00",
    "code": "002370"
  },
  {
    "title": "拟定增募资13亿拓展产业链 亚太药业封涨停",
    "href": "http://stock.jrj.com.cn/2015/10/22081719963726.shtml",
    "datetime": "2015-10-22 08:17:00",
    "code": "002370"
  }
]